|
|
|
|
| LEADER |
00000pam a2200000 a 4500 |
| 001 |
2565360 |
| 003 |
ICU |
| 005 |
20030522210600.0 |
| 008 |
960213s1996 paua b 001 0 eng c |
| 010 |
|
|
|a 96010271
|
| 020 |
|
|
|a 0397514565
|
| 035 |
|
|
|a (NhCcYBP)YBT 96010271
|
| 035 |
|
|
|a (NhCcYBP)YBP97023111603
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OrLoB-B
|d OCoLC
|
| 050 |
1 |
0 |
|a RC660
|b .D4544 1996
|
| 060 |
1 |
0 |
|a WK 810 D536 1996
|
| 082 |
0 |
0 |
|a 616.4/62
|2 20
|
| 245 |
0 |
0 |
|a Diabetes mellitus :
|b a fundamental and clinical text /
|c edited by Derek LeRoith, Simeon Taylor, Jerrold M. Olefsky ; with 176 additional contributors.
|
| 260 |
|
|
|a Philadelphia :
|b Lippincott-Raven,
|c c1996.
|
| 300 |
|
|
|a xx, 876 p. :
|b ill. ;
|c 29 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Pt. I.
|t Insulin Secretion.
|g 1.
|t Insulin Secretion in Humans: Physiologic Regulation and Alteration in Disease States /
|r Maria M. Byrne, Jeppe Sturis, Niall M. O'Meara and Kenneth S. Polonsky.
|g 2.
|t Kinetics of Insulin Secretion: Current Implications /
|r Gerold M. Grodsky.
|g 3.
|t Insulin Gene Regulation /
|r Giulia Kennedy and Michael German.
|g 4.
|t Processing of the Insulin Molecule /
|r Christopher J. Rhodes.
|g 5.
|t The Role of Glucose Transport and Phosphorylation in Glucose-Stimulated Insulin Secretion /
|r John H. Johnson and Christopher B. Newgard.
|g 6.
|t GTP-Binding Proteins and Regulation of Pancreatic Islet Function: Part I. Heterotrimeric Proteins, Insulin Gene Expression, and Insulin Secretion /
|r R. Paul Robertson, Elizabeth R. Seaquist, Timothy F. Walseth, Hui-Jian Zhang, J. Bruce Redmon, Vincent Poitout and David M. Kendall.
|g 7.
|t GTP-Binding Proteins in the Regulation of Pancreatic [beta]-Cell Function: Part II. Putative Roles for Low-Molecular-Weight Proteins /
|r Stewart A. Metz and Anjaneyulu Kowluru.
|g 8.
|t Insulinotropic Glucagon-Like Peptides /
|r Joel F. Habener.
|g 9.
|t Electrophysiology of the Pancreatic [beta]-Cell /
|r Illani J. Atwater, David Mears and Eduardo Roja.
|g 10.
|t Detrimental Effects of Chronic Hyperglycemia on the Pancreatic [beta]-Cell /
|r Jack L. Leahy.
|g 11.
|t Islet Amyloid and Its Potential Role in the Pathogenesis of Type II Diabetes Mellitus /
|r Peter C. Butler --
|g Pt. II.
|t Insulin Action.
|g 12.
|t Physiologic Action of Insulin /
|r Paul Flakoll, Michael G. Carlson and Alan Cherrington.
|g 13.
|t Glucose Counter-regulatory Hormones: Physiology, Pathophysiology and Relevance to Clinical Hypoglycemia /
|r Philip E. Cryer.
|g 14.
|t The Biochemistry of Insulin Action /
|r Bentley Cheatham and C. Ronald Kahn.
|g 15.
|t The Insulin Receptor /
|r Jeffrey S. Flier.
|g 16.
|t The Role of IRS-1 During Insulin Signaling /
|r Morris F. White.
|g 17.
|t Small GTPases and (Serine/Threonine) Protein Kinase Cascades in Insulin Signal Transduction /
|r Joseph Avruch.
|g 18.
|t Protein-Tyrosine Phosphatases and the Regulation of Insulin Action /
|r Barry J. Goldstein.
|g 19.
|t Protein Kinase C /
|r Robert V. Farese.
|g 20.
|t A Role for Insulin-Mediated Regulation of Cyclic Guanosine Monophosphate (cGMP)-Inhibited Phosphodiesterase in the Antilipolytic Action of Insulin /
|r Eva Degerman, Marie J. Leroy, Masato Taira, Per Belfrage and Vincent Manganiello.
|g 21.
|t Insulin Action on Glucose Transport /
|r Michael P. Czech, James L. Erwin and Mark W. Sleeman.
|g 22.
|t Regulation of Glycogen Synthesis /
|r Alexander V. Skurat and Peter J. Roach.
|g 23.
|t Hormone-Sensitive Lipase and the Control of Lipolysis in Adipocytes /
|r Constantine Londos.
|g 24.
|t Insulin and Intracellular Ions /
|r Boris Draznin and Jane E. B. Reusch.
|g 25.
|t Gene Regulation /
|r Richard M. O'Brien and Daryl K. Grantier.
|g 26.
|t Insulin Degradation /
|r Andrew Becker, Li Ding and Richard A. Roth --
|g Pt. III.
|t Definition/Classification.
|g 27.
|t Definition and Classification of Diabetes Including Maturity-Onset Diabetes of the Young /
|r Stefan S. Fajans --
|g Pt. IV.
|t Type I Diabetes.
|g 28.
|t Interaction of Some Biochemical and Physiologic Effects of Insulin That May Play a Role in the Control of Blood Glucose Concentration /
|r Eric A. Newsholme and G. D. Dimitriadis.
|g 29.
|t Diabetes Ketoacidosis and the Hyperglycemic Hyperosmolar Syndrome /
|r Elizabeth D. Ennis and Robert A. Kreisberg.
|g 30.
|t Natural History of Autoimmunity in Type I Diabetes Mellitus /
|r Charles F. Verge and George S. Eisenbarth.
|g 31.
|t Humoral Autoimmunity /
|r Alberto Falorni and Ake Lernmark.
|g 32.
|t Autoantibodies and the Disease Process of Insulin-Dependent Diabetes Mellitus /
|r Carla J. Greenbaum and Jerry P. Palmer.
|g 33.
|t Roles of Cell-Mediated Immunity and Cytokines in the Pathogenesis of Insulin-Dependent Diabetes Mellitus /
|r Alex Rabinovitch.
|g 34.
|t Major Histocompatibility Locus and Other Genes That Determine the Risk of Development of Insulin-Dependent Diabetes Mellitus /
|r Susan Faas and Massimo Trucco.
|g 35.
|t Association Between Insulin-Dependent Diabetes Mellitus and Other Autoimmune Diseases /
|r Pina L. Balducci-Silano, Ellen Connor and Noel K. Maclaren.
|g 36.
|t Role of Viruses in the Pathogenesis of Insulin-Dependent Diabetes Mellitus /
|r Ji-Won Yoon.
|g 37.
|t Animal Models of Autoimmune Diabetes Mellitus /
|r John P. Mordes, Dale L. Greiner and Aldo A. Rossini.
|g 38.
|t Transgenic and Gene Targeting Strategies in Insulin-Dependent Diabetes /
|r Leonard C. Harrison and Thomas W. H. Kay --
|g Pt. V.
|t Type I Diabetes: Therapeutics.
|g 39.
|t The Treatment of Diabetes to Prevent and Delay Long-Term Complications: The Diabetes Control and Complications Trial /
|r David M. Nathan.
|g 40.
|t Translation of the Diabetes Control and Complications Trial /
|r Saul Genuth.
|g 41.
|t Diet Therapy in Type I Diabetes /
|r Christine Beebe.
|g 42.
|t Exercise for the Patient with Insulin-Dependent Diabetes Mellitus /
|r Edward S. Horton.
|g 43.
|t Immune Intervention /
|r Jay S. Skyler and Jennifer B. Marks.
|g 44.
|t Islet Cell Transplantation /
|r Norma S. Kenyon, Camillo Ricordi and Daniel H. Mintz.
|g 45.
|t Pancreas Transplantation /
|r David E. R. Sutherland, Ranier W. G. Gruessner, Kenneth Bravman and Angelika Gruessner.
|g 46.
|t Gene Therapy for Metabolic Disease /
|r Daniel Rader, Steven E. Raper and James M. Wilson.
|g 47.
|t Engineering the Pancreatic [beta]-cell /
|r Shimon Efrat and Norman Fleischer.
|g 48.
|t Principles and Fundamentals of Glucose Monitoring /
|r Ebtisam Wilkins, Plamen Atanasov and David S. Schade --
|g Pt. VI.
|t Type II Diabetes.
|g 49.
|t Epidemiology of Non-Insulin-Dependent Diabetes /
|r Peter H. Bennett.
|g 50.
|t Metabolic Abnormalities in the Development of Non-Insulin-Dependent Diabetes Mellitus /
|r Clifton Bogardus.
|g 51.
|t Impaired Glucose Tolerance: Risk Factor or Diagnostic Category /
|r Michael P. Stern.
|g 52.
|t Obesity in Non-Insulin-Dependent Diabetes Mellitus /
|r Henning Beck-Nielsen and Ole Hother-Nielsen.
|g 53.
|t Effects of Aging on Glucose Homeostasis /
|r Jeffrey B. Halter.
|g 54.
|t Drug-Induced Diabetes /
|r Richard J. Comi.
|g 55.
|t Non-Insulin-Dependent Diabetes Mellitus Secondary to Other Endocrine Disorders /
|r Michael Berelowitz and Eugene How Go.
|g 56.
|t Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus /
|r Gordon C. Weir and Susan Bonner-Weir.
|g 57.
|t Insulin Resistance and Its Consequences: Non-Insulin-Dependent Diabetes Mellitus and Coronary Heart Disease /
|r Gerald M. Reaven.
|g 58.
|t Biochemical Defects of Insulin Action in Humans /
|r Jose F. Caro.
|g 59.
|t Glucose Transporters and Pathophysiologic States /
|r E. Dale Abel, Peter R. Shepherd and Barbara B. Kahn.
|g 60.
|t Glucose "Toxicity": Effect of Chronic Hyperglycemia on Insulin Action /
|r Luciano Rossetti.
|g 61.
|t TNF-[alpha] and the Insulin Resistance of Obesity /
|r Gokhan S. Hotamisligil and Bruce M. Spiegelman.
|g 62.
|t Positional Cloning Strategies to Identify Causal Genes for Non-Insulin-Dependent Diabetes Mellitus /
|r Stephen S. Rich.
|g 63.
|t Candidate Genes for Non-Insulin-Dependent Diabetes Mellitus /
|r Alan R. Shuldiner and Kristi D. Silver.
|g 64.
|t Mutations in the Genes Encoding the Insulin Receptor and Insulin Receptor Substrate-1 /
|r Simeon I. Taylor and Domenico Accili.
|g 65.
|t Clinical Syndromes Associated with Insulin Resistance /
|r David F. Moller.
|g 66.
|t Maternally Inherited Diabetes and Deafness: New Subtype of Diabetes Mellitus /
|r Takashi Kadowaki.
|g 67.
|t Primate Animal Models of Non-Insulin-Dependent Diabetes Mellitus /
|r Barbara Hansen.
|g 68.
|t Rodent Genetic Models for Obesity and Non-Insulin-Dependent Diabetes Mellitus /
|r Fred T. Fiedorek, Jr. --
|g Pt. VII.
|t Type II Diabetes: Therapeutics.
|g 69.
|t Prevention Strategies for Non-Insulin-Dependent Diabetes Mellitus: An Economic Perspective /
|r Richard C. Eastman, Jonathan C. Javitt, William H. Herman, Eric J. Dasbach and Maureen I. Harris.
|g 70.
|t Dietary Therapy in Non-Insulin-Dependent Diabetes Mellitus: Spreading the Nutrient Load /
|r David J. A. Jenkins and Alexandra L. Jenkins.
|g 71.
|t Exercise in Patients with Non-Insulin-Dependent Diabetes Mellitus /
|r Edward S. Horton.
|g 72.
|t [alpha]-Glucosidase Inhibitors in the Treatment of Diabetes /
|r John M. Amatruda.
|g 73.
|t Intensive Insulin Therapy for Patients with Type II Diabetes /
|r Steven V. Edelman and Robert R. Henry.
|
| 505 |
8 |
0 |
|g 74.
|t New Therapies for Non-Insulin-Dependent Diabetes Mellitus: Thiazolidinediones /
|r Randall W. Whitcomb, Alan R. Saltiel and Dean H. Lockwood.
|g 75.
|t Fatty Acid Oxidation Inhibitors /
|r James E. Foley and Robert Anderson --
|g Pt. VIII.
|t Pregnancy.
|g 76.
|t Intermediary Metabolism During Pregnancy: Implications for Diabetes Mellitus /
|r Thomas A. Buchanan.
|g 77.
|t Effects of Maternal Diabetes on Intrauterine Development /
|r Thomas A. Buchanan.
|g 78.
|t Pregnancy and Complications of Type I Diabetes: Maternal and Fetal Implications /
|r Barak M. Rosenn and Menachem Miodovnik.
|g 79.
|t Gestational Diabetes Mellitus /
|r Robert E. Ratner --
|g Pt. IX.
|t Complications : Descriptive and Clinical.
|g 80.
|t Pathophysiology of Diabetic Retinopathy /
|r Zhen Y. Jiang, Hamish M. A. Towler, Philip Luthert and Susan Lightman.
|g 81.
|t Pathophysiology of Diabetic Nephropathy /
|r Roberto Trevisan and GianCarlo Viberti.
|g 82.
|t Diabetic Neuropathies: An Overview of Clinical Aspects /
|r Aaron I. Vinik, Pauline Newlon, Zvonko Milicevic, Patricia McNitt and Kevin B. Stausberry.
|g 83.
|t Autoimmune Mechanisms of Diabetic Neuropathy /
|r Gary L. Pittenger, Zvonko Milicevic and Aaron I. Vinik.
|g 84.
|t Microvascular and Compression Mechanisms in the Etiology of Diabetic Neuropathy /
|r Michael A. Hill, Lawrence B. Colen and Aaron I. Vinik.
|g 85.
|t Neuropathy: Growth Factors and Nerve Regeneration /
|r Francis J. Liuzzi and Alison S. Depto.
|g 86.
|t Diabetes, Lipids, and Artherosclerosis /
|r Alan Chait and John D. Brunzell.
|g 87.
|t Pathogenesis of Hypertension in Diabetes /
|r Naftali Stern and Michael L. Tuck.
|g 88.
|t Macrovascular Complications of Diabetes Mellitus /
|r Barbara V. Howard --
|g Pt. X.
|t Complications : Mechanisms.
|g 89.
|t The Sorbitol-Osmotic and Sorbitol-Redox Hypothesis /
|r Douglas A. Greene and Martin J. Stevens.
|g 90.
|t Advanced Glycation End Products and the Pathogenesis of Diabetic Complications /
|r Hans-Peter Hammes and Michael Brownlee.
|g 91.
|t Hyperinsulinemia /
|r Ele Ferrannini.
|g 92.
|t The Role of Growth Factors in the Pathogenesis of Diabetic Vascular Complications /
|r Vicky A. Blakesley and Derek LeRoith.
|g 93.
|t Pathogenesis of Platelet Dysfunction in Diabetes /
|r Roger D. Nolan and Aaron I. Vinik.
|g 94.
|t Free Radicals, Nitric Oxide, and Diabetic Complications /
|r Jerry L. Nadler and Lori Winer.
|
| 650 |
|
0 |
|a Diabetes
|x Pathophysiology.
|
| 650 |
|
0 |
|a Diabetes
|x Molecular aspects.
|
| 650 |
1 |
2 |
|a Diabetes Mellitus.
|
| 650 |
|
7 |
|a Diabetes
|x Molecular aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst00892173
|
| 650 |
|
7 |
|a Diabetes
|x Pathophysiology.
|2 fast
|0 http://id.worldcat.org/fast/fst00892180
|
| 700 |
1 |
|
|a LeRoith, Derek,
|d 1945-
|0 http://id.loc.gov/authorities/names/n84172371
|1 http://viaf.org/viaf/32077302
|
| 700 |
1 |
|
|a Taylor, Simeon I.
|0 http://id.loc.gov/authorities/names/n89139570
|1 http://viaf.org/viaf/19828130
|
| 700 |
1 |
|
|a Olefsky, Jerrold M.
|0 http://id.loc.gov/authorities/names/n84176253
|1 http://viaf.org/viaf/27215831
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)34283135
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i d6ec18b0-249e-5e0e-8f8b-3c909c882ec2
|s 8211cd60-1f18-568c-ad3c-759c6a9b0828
|
| 928 |
|
|
|t Library of Congress classification
|a RC660 .D4544 1996
|l JCL
|c JCL-Sci
|i 3460785
|
| 927 |
|
|
|t Library of Congress classification
|a RC660 .D4544 1996
|l JCL
|c JCL-Sci
|e CRERAR
|b 45377044
|i 4746312
|
